Myocardial infarction, hypovitaminosis D and vitiligo [55]

Revista Portuguesa de Cardiologia

Volumn 29, Issue 5, 2010, Pages 839-840

  Nunes, José Pedro L ^a   Martins, Carla S ^b  

^a University of Porto   (Portugal)

^b HOSPITAL DE SÃO JOÃO   (Portugal)

Author keywords

Hypovitaminosis D; Myocardial infarction; Vitiligo

Indexed keywords

25 HYDROXYVITAMIN D; ACETYLSALICYLIC ACID; BISOPROLOL; CANDESARTAN; CLOPIDOGREL; ISOSORBIDE MONONITRATE; LISINOPRIL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PRAVASTATIN; TROPONIN I;

AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CASE REPORT; CIGARETTE SMOKING; CLINICAL ASSESSMENT; CORONARY ARTERY OBSTRUCTION; DISEASE ASSOCIATION; HEART INFARCTION; HUMAN; HYPERTENSION; MALE; OBESITY; SLEEP APNEA SYNDROME; T WAVE INVERSION; THORAX PAIN; VITAMIN D DEFICIENCY; VITILIGO; COMPLICATION; MYOCARDIAL INFARCTION;

AGED; HUMANS; MALE; MYOCARDIAL INFARCTION; VITAMIN D DEFICIENCY; VITILIGO;

EID: 77955960577     PISSN: 08702551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Giovannucci E, Liu Y, Hollis BW, Rim EB. 25-Hydroxyvitamin D and risk of myocardial infarction in men. Arch Int Med 2008; 168: 1174-1180.
2. Dobnig H, Pilz S, Scharnagl H, et al. Independent association of low serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin levels with all-cause and cardiovascular mortality. Arch Int Med 2008; 168: 1340-1349.
3. Grimes PE. New insights and new therapies in vitiligo. JAMA 2005; 293: 730-735.
4. Pérez-Castrillón JL, Vega G, Abad L, et al. Effects of atorvastatin on vitamin D levels in patients with acute ischemic heart disease. Am J Cardiol 2007; 99: 903-905.
5. Noel M, Gagné C, Bergeron J, Jobin J, Poirier P. Positive pleiotropic effects of HMG-CoA reductase inhibitor on vitiligo. Lipids Health Dis 2004; 3: 7.